Rattanaumpawan, P., Jirajariyavej, S., Lerdlamyong, K., Palavutitotai, N., & Saiyarin, J. (2022). Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand. MDPI AG.
Chicago Style (17th ed.) CitationRattanaumpawan, Pinyo, Supunnee Jirajariyavej, Kanokorn Lerdlamyong, Nattawan Palavutitotai, and Jatuporn Saiyarin. Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand. MDPI AG, 2022.
MLA (9th ed.) CitationRattanaumpawan, Pinyo, et al. Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand. MDPI AG, 2022.